BioSpace News Archive

Phase 1 complete, Phase 2 underway; Nearly 400,000 square foot facility to eventually house four of Prime’s Minnesota offices

“CigFree SmartBand” is The First All-Natural Healthy Non-Invasive Low-cost Affordable Solution for Quitting Smoking

12 presentations highlighting latest data from Ionis’ Neurodegenerative Program.

Legal cannabis industry leaders join forces to educate new market entrants at regional InterCannAlliance Symposia in Latin America, Europe, Asia and Africa

Namodenoson seeks to address a major unmet need for Child Pugh B patients with advanced liver cancer

410 Medical, Inc. today announced a recent publication in Open Access Emergency Medicine.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2018 and updated its full-year 2018 financial outlook.

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the third quarter of 2018 after the market close on Wednesday, November 7, 2018.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the license agreement and research collaboration and option agreement between Arrowhead and Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the stock purchase agreement between Arrowhead and Johnson & Johnson Innovation – JJDC, Inc., (JJDC) have closed,

November is National Epilepsy Awareness Month and the Epilepsy Foundation is kicking off a fundraiser in partnership with online fundraising platform, Omaze.